This Point of Care (POC) Drugs of Abuse Testing Market research report presents a detailed analysis based on through research of the overall market, particularly on question that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis and competitive analysis of the market.  This research is conducted to understand the current landscape of the market. This will shape the future of the market and foresee the extent of the competition of the market. This Point of Care (POC) Drugs of Abuse Testing Market report will also help all the manufacturers and investors to have a better understanding of the direction in which the market is headed.

The Point of Care (POC) Drugs of Abuse Testing Market report can effectively help companies and decision makers in addressing the challenges strategically to gain the maximum benefits in this highly competitive market.  The leading players of the Point of Care (POC) Drugs of Abuse Testing Market industry, their market share, product portfolio, company profiles are covered in this Point of Care (POC) Drugs of Abuse Testing Market report.  The competitive market scenario among the top market players will help the industry aspirants in planning their strategies. The statistics offered in the report will be precise and useful guide to shape the business growth.

Data Bridge Market Research analyses the market to account from USD 1625.14 million in 2020 to USD 2311.12 million by 2028 growing at a CAGR of 4.50% in the above-mentioned forecast period.

Definition

Drugs of abuse is basically the illegal prescribed substances consumed for a non-medical purpose. The point of care (POC) drugs of abuse testing deals with the detection of illegal substances in the urine, blood, saliva, hair or sweat which is done at a specified testing location rather than the sample being sent to a laboratory.

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-poc-drugs-of-abuse-testing-market 

Key Growth Drivers:

The high prevalence of drug abuse in individuals especially teenagers and the usage of point of care drugs of abuse testing in sports are primarily driving the growth of the point of care (POC) drugs of abuse testing market. Additionally, the known advantages of point of care drugs of abuse testing such as reduced potential for contamination or deterioration, fewer requirements to aliquot specimens or store samples and portability are the reason for high adoption and usage of point of care (POC) drugs of abuse testing. On the other hand, the point of care testing devices may not be as reliable and accurate as compared to the laboratory-based testing’s due to high probability of falser positive or negative results which might restrain the overall growth of the market. The increasing number of regulatory approvals for and the rising usage of home-based point of care devices is estimated to generate new opportunities within the forecast period.

However, the factor such as narrow detection range and less ability to differentiate between similar drugs in same category in the testing is projected to be major challenge for the market’s growth.

The report emphasizes the participation of key entities, notably:

uest Diagnostics Incorporated, Abbott, AdvaCare Pharma, Cliawaived Inc., DRUGSCAN, Millennium Health, BD, Agilent Technologies Inc., Danaher, Bio-Rad Laboratories Inc., Cellavision, JOYSBIO (Tianjin) Biotechnology Co., Ltd, NIHON KOHDEN CORPORATION, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Sysmex Corporation, Merck KGaA, Cardinal Health, Takara Bio Inc., bioMérieux SA, Enzo Life Sciences Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Key Market Perspectives:

• Thorough examination of prevailing market tendencies
• Updates on the latest product advancements and innovations
• Point of Care (POC) Drugs of Abuse Testing Market Compound Annual Growth Rate (CAGR) for both historic and forecasted years
• Strategies and activities of prominent players and brands in the field
• Insights into the industry landscape for emerging participants

Gain Additional Insight from This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-point-of-care-poc-drugs-of-abuse-testing-market 

Key Market Segmentation

By Drugs Type (Amphetamines, Barbiturates, Benzodiazepines, Cannibinoids, Cocaine, Methadone, Opiates, Phencyclidine), Product (Analysers, Rapid Testing Devices, Consumables),  Sample Type (Saliva, Urine, Blood, Others), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Others)

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-metallic-biomaterial-market 

https://www.databridgemarketresearch.com/reports/global-point-of-care-poc-drugs-of-abuse-testing-market 

https://www.databridgemarketresearch.com/reports/global-graphene-infused-packaging-market 

https://www.databridgemarketresearch.com/reports/global-toothbrush-sterilizer-market 

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research operates as a multinational management-consulting firm, boasting offices situated in both India and Canada. Renowned for our innovative and cutting-edge market analysis methodologies, we pride ourselves on our unparalleled durability and forward-thinking approaches. Our commitment lies in unravelling optimal consumer prospects and nurturing invaluable insights to empower your company's success within the market.

With a team comprising over 500 analysts specializing in various industries, we have been instrumental in serving over 40% of Fortune 500 companies on a global scale. Our extensive network boasts a clientele exceeding 5000+, spanning across the globe. At Data Bridge Market Research, our goal remains steadfast: to provide comprehensive market intelligence and strategic guidance to propel your business toward success.

Contact Us

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975
Email – corporatesales@databridgemarketresearch.com